KAT2A
Summary: KAT2A, or GCN5, is a histone acetyltransferase (HAT) that functions primarily as a transcriptional activator. It also functions as a repressor of NF-kappa-B (see MIM 164011) by promoting ubiquitination of the NF-kappa-B subunit RELA (MIM 164014) in a HAT-independent manner (Mao et al., 2009 [PubMed 19339690]).[supplied by OMIM, Sep 2009].
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:602301 Ensembl IDEnsembl:ENSG00000108773 HGNC IDHGNC:HGNC:4201 PHARMGKB IDPA162392664 Map Location17q21.2 |
GO terms in KAT2A
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0001701 | in utero embryonic development |
BP | IEA | GO:0001756 | somitogenesis |
BP | ISS | GO:0001816 | cytokine production |
BP | IEA | GO:0001843 | neural tube closure |
BP | TAS | GO:0006338 | chromatin remodeling |
BP | TAS | GO:0006357 | regulation of transcription by RNA polymerase II |
Gene expression in normal tissue: KAT2A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in KAT2A
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP268 | Notch Signaling Pathway |
wikipathways | WP4242 | Notch Signaling Pathway |
pid | e2f_pathway | E2F transcription factor network |
pid | myc_activpathway | Validated targets of C-MYC transcriptional activation |
pid | myc_pathway | C-MYC pathway |
pid | p53downstreampathway | Direct p53 effectors |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in KAT2A
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |